As of 2026-05-24, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -4.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 91.73 mil USD. MEIP's TTM EBITDA according to its financial statements is -21.71 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 15.2x | 14.7x |
| Forward P/E multiples | 16.5x - 20.7x | 18.8x |
| Fair Price | (10.57) - 10.82 | (0.43) |
| Upside | -444.2% - 252.5% | -114.1% |
| Date | EV/EBITDA |